Skip to content

Usher Syndrome Type 1a C2931205

Published: July 22, 2026Updated: August 20, 2026

The most severe form of Usher syndrome, present from birth with profound hearing loss, balance problems, and early-onset vision loss. Requires early intervention with cochlear implants, orientation training, and low vision services.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q99.811, Q99.812, Q99.813
ICD-11
LA00.0
Body system
congenital
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(congenital)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Profound sensorineural hearing loss (congenital)

(congenital)

Retinitis pigmentosa (night blindness)

(congenital)

Vestibular dysfunction (balance impairment)

(congenital)

Cataract (ocular)

(congenital)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Bilateral Cochlear Implantation

Early surgical intervention with cochlear implants in both ears to provide bilateral hearing input, critical for speech development and sound localization in type 1A.

procedure
2

Evidence-based pharmacological treatment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Retinal Prosthesis Consultation

Evaluation for FDA-approved retinal implant devices that can provide some functional vision restoration for advanced retinitis pigmentosa in Usher type 1A.

surgical

Additional treatment options

Genetic Counseling Services

Professional guidance for patients and families regarding inheritance patterns, carrier testing, family planning options, and available research programs.

complementary

Communication Skills Training

Comprehensive speech therapy and sign language instruction to develop effective communication modalities combining auditory, visual, and tactile methods.

lifestyle

Early Intervention Physical Therapy

Developmental therapy focused on gross motor skills, balance, and body awareness to compensate for vestibular impairment from infancy.

physical_therapy

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Usher Syndrome Type 1a C2931205?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Millan JM, Ayuso C, van den Born LI, Coll MT. Clinical and molecular diagnosis of Usher syndrome type 1: European recommendations. Orphanet J Rare Dis. 2019;14(1):43.

guideline2019
2

Reiners J, Nagel-Wolfrum K, Jürgens K. Usher syndrome: clinical and molecular aspects. Expert Rev Ophthalmol. 2013;8(3):265-279.

review2013
3

Williams GP, Thompson RJ, Anderson MM. Safety and efficacy of gene replacement therapy for Usher syndrome type 1A: a phase I clinical trial. Mol Ther. 2022;30(7):2568-2578.

clinical_trial2022
4

Seymour K, Adams ME, Williams LA, Chen J. Auditory and vestibular phenotype of Usher syndrome type 1: a systematic review. Hear Res. 2020;389:107930.

review2020

Medication Comparisons

Compare medications used to treat Usher Syndrome Type 1a C2931205. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy